Insights

Neurology focus Adamas specializes in innovative neurological medicines with a mission to reduce the burden of neurological diseases, presenting opportunities to cross-sell or partner on therapies addressing Parkinson's disease, epileptic conditions, and related neurodegenerative indications.

Recent acquisition The company was acquired by Supernus Pharmaceuticals in 2021 for about $400 million, indicating a consolidation move and potential alignment opportunities for portfolio integration, licensing, or co-development deals with a larger Parkinson’s and neurology-focused platform.

Financial position Current revenue range is modest (approximately $50M–$100M) with a lean employee base, suggesting a need for strategic partnerships or external funding to scale commercialization, clinical programs, or manufacturing capacity.

Clinical milestones Gocovri has FDA-approved second indication and off-episode management in Parkinson’s disease, signaling ongoing clinical and regulatory momentum that could open doors for additional co-development, rare-disease, or expansion collaborations.

Market positioning Operating as a fully integrated but small-cap biotech in a competitive neurology space with peers of varying scale, Adamas presents opportunities for sales partnerships, contract manufacturing, or distribution agreements to broaden reach and leverage established networks.

Similar companies to Adamas Pharmaceuticals, Inc.

Adamas Pharmaceuticals, Inc. Tech Stack

Adamas Pharmaceuticals, Inc. uses 8 technology products and services including W3 Total Cache, HIPAA, Microsoft Dynamics 365 for Operations, and more. Explore Adamas Pharmaceuticals, Inc.'s tech stack below.

  • W3 Total Cache
    Caching
  • HIPAA
    Electronic Health Records
  • Microsoft Dynamics 365 for Operations
    Enterprise Resource Planning
  • Underscore.js
    Javascript Libraries
  • PCI DSS
    Risk And Compliance
  • Adobe Tag Manager
    Tag Management
  • SAP Concur
    Travel And Expense Management
  • Google Analytics
    Web Analytics

Media & News

Adamas Pharmaceuticals, Inc.'s Email Address Formats

Adamas Pharmaceuticals, Inc. uses at least 1 format(s):
Adamas Pharmaceuticals, Inc. Email FormatsExamplePercentage
FLast@adamaspharma.comJDoe@adamaspharma.com
93%
First.Last@adamaspharma.comJohn.Doe@adamaspharma.com
3%
FirstLast@adamaspharma.comJohnDoe@adamaspharma.com
3%
LastF@adamaspharma.comDoeJ@adamaspharma.com
1%

Frequently Asked Questions

Where is Adamas Pharmaceuticals, Inc.'s headquarters located?

Minus sign iconPlus sign icon
Adamas Pharmaceuticals, Inc.'s main headquarters is located at Emeryville, California United States. The company has employees across 4 continents, including North AmericaAsiaAfrica.

What is Adamas Pharmaceuticals, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Adamas Pharmaceuticals, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Adamas Pharmaceuticals, Inc.'s stock symbol?

Minus sign iconPlus sign icon
Adamas Pharmaceuticals, Inc. is a publicly traded company; the company's stock symbol is ADMS.

What is Adamas Pharmaceuticals, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Adamas Pharmaceuticals, Inc.'s official website is adamaspharma.com and has social profiles on LinkedInCrunchbase.

What is Adamas Pharmaceuticals, Inc.'s NAICS code?

Minus sign iconPlus sign icon
Adamas Pharmaceuticals, Inc.'s NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Adamas Pharmaceuticals, Inc. have currently?

Minus sign iconPlus sign icon
As of April 2026, Adamas Pharmaceuticals, Inc. has approximately 44 employees across 4 continents, including North AmericaAsiaAfrica. Key team members include Chief Accounting Officer: C. P.Vice President Of Pharmacy Operations: J. N.Vice President Of Operations: K. G.. Explore Adamas Pharmaceuticals, Inc.'s employee directory with LeadIQ.

What industry does Adamas Pharmaceuticals, Inc. belong to?

Minus sign iconPlus sign icon
Adamas Pharmaceuticals, Inc. operates in the Pharmaceutical Manufacturing industry.

What technology does Adamas Pharmaceuticals, Inc. use?

Minus sign iconPlus sign icon
Adamas Pharmaceuticals, Inc.'s tech stack includes W3 Total CacheHIPAAMicrosoft Dynamics 365 for OperationsUnderscore.jsPCI DSSAdobe Tag ManagerSAP ConcurGoogle Analytics.

What is Adamas Pharmaceuticals, Inc.'s email format?

Minus sign iconPlus sign icon
Adamas Pharmaceuticals, Inc.'s email format typically follows the pattern of FLast@adamaspharma.com. Find more Adamas Pharmaceuticals, Inc. email formats with LeadIQ.

When was Adamas Pharmaceuticals, Inc. founded?

Minus sign iconPlus sign icon
Adamas Pharmaceuticals, Inc. was founded in 2002.
Adamas Pharmaceuticals, Inc. logo

Adamas Pharmaceuticals, Inc.

Pharmaceutical ManufacturingCalifornia, United States11-50 Employees

Adamas Pharmaceuticals, Inc. is a small pharmaceutical manufacturing company based in Emeryville, California, focused on developing medicines for neurological disorders. Its mission is to deliver innovative therapies aimed at reducing the burden of neurological disease on patients, their caregivers, and society. The company positions itself as fully integrated and intent on growing a portfolio of therapies across a spectrum of neurological conditions. In early 2021, Adamas announced FDA approval for a second indication of its Parkinson's disease treatment Gocovri, expanding its use to address off episodes. It also launched Picture More Time, a national disease-education campaign to raise awareness of motor complications in Parkinson's disease.

Section iconCompany Overview

Headquarters
Emeryville, California United States
Phone number
Stock Symbol
ADMS
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2002
Employees
11-50

Section iconFunding & Financials

  • $50M$100M

    Adamas Pharmaceuticals, Inc.'s revenue is estimated to be in the range of $50M$100M

Section iconFunding & Financials

  • $50M$100M

    Adamas Pharmaceuticals, Inc.'s revenue is estimated to be in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.